Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 3
1997 5
1998 3
1999 2
2000 1
2001 5
2002 3
2003 4
2004 3
2005 1
2006 2
2007 2
2008 2
2009 6
2010 2
2011 11
2012 8
2013 11
2014 10
2015 17
2016 11
2017 12
2018 15
2019 17
2020 16
2021 11
2022 19
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Comorbidity in multiple sclerosis and related disorders.
Barzegar M, Drulovic J, Nociti V. Barzegar M, et al. Among authors: drulovic j. Front Immunol. 2024 Aug 19;15:1469614. doi: 10.3389/fimmu.2024.1469614. eCollection 2024. Front Immunol. 2024. PMID: 39224587 Free PMC article. No abstract available.
Managing MS in a changing treatment landscape.
Duddy M, Haghikia A, Cocco E, Eggers C, Drulovic J, Carmona O, Zéphir H, Gold R. Duddy M, et al. Among authors: drulovic j. J Neurol. 2011 May;258(5):728-39. doi: 10.1007/s00415-011-6009-x. Epub 2011 Mar 25. J Neurol. 2011. PMID: 21437661 Review.
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.
De Vito F, Musella A, Fresegna D, Rizzo FR, Gentile A, Stampanoni Bassi M, Gilio L, Buttari F, Procaccini C, Colamatteo A, Bullitta S, Guadalupi L, Caioli S, Vanni V, Balletta S, Sanna K, Bruno A, Dolcetti E, Furlan R, Finardi A, Licursi V, Drulovic J, Pekmezovic T, Fusco C, Bruzzaniti S, Hornstein E, Uccelli A, Salvetti M, Matarese G, Centonze D, Mandolesi G. De Vito F, et al. Among authors: drulovic j. Neuropathol Appl Neurobiol. 2022 Feb;48(2):e12765. doi: 10.1111/nan.12765. Epub 2021 Oct 6. Neuropathol Appl Neurobiol. 2022. PMID: 34490928 Free PMC article.
Heroin-induced acute longitudinally extensive transverse myelopathy.
Dujmovic I, Nikolic I, Martinovic V, Mesaros S, Drulovic J. Dujmovic I, et al. Among authors: drulovic j. Neurol Sci. 2018 Apr;39(4):791-792. doi: 10.1007/s10072-017-3197-x. Epub 2017 Nov 17. Neurol Sci. 2018. PMID: 29149398 No abstract available.
Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers.
Adamec I, Brecl Jakob G, Rajda C, Drulović J, Radulović L, Bašić Kes V, Lazibat I, Rimac J, Cindrić I, Gržinčić T, Abičić A, Barun B, Gabelić T, Gomezelj S, Mesaroš Š, Pekmezović T, Klivényi P, Krbot Skorić M, Habek M. Adamec I, et al. Among authors: drulovic j. J Neuroimmunol. 2023 Sep 15;382:578164. doi: 10.1016/j.jneuroim.2023.578164. Epub 2023 Jul 27. J Neuroimmunol. 2023. PMID: 37536052
The epidemiology of multiple sclerosis in Europe.
Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L, Milanov I. Pugliatti M, et al. Among authors: drulovic j. Eur J Neurol. 2006 Jul;13(7):700-22. doi: 10.1111/j.1468-1331.2006.01342.x. Eur J Neurol. 2006. PMID: 16834700 Free article. Review.
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Singer BA, Arnold DL, Drulovic J, Freedman MS, Gold R, Gudesblatt M, Jasinska E, LaGanke CC, Naismith RT, Negroski D, Oh J, Hernandez Perez MA, Selmaj K, Then Bergh F, Wundes A, Ziemssen T, Castro-Borrero W, Chen H, Levin S, Scaramozza M, Shankar SL, Wang T, Wray S. Singer BA, et al. Among authors: drulovic j. Mult Scler. 2023 Dec;29(14):1795-1807. doi: 10.1177/13524585231205708. Epub 2023 Oct 31. Mult Scler. 2023. PMID: 37905526 Free PMC article.
181 results